Drug maker Merck will make a third attempt Thursday to convince the government to allow its cholesterol-lowering pill Mevacor to be sold without a prescription.
Drug maker Merck will make a third attempt Thursday to convince the government to allow its cholesterol-lowering pill Mevacor to be sold without a prescription.
